Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Global Forecast to 2028

Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Global Forecast to 2028



The global plasma fractionation market size is projected to reach USD 40.4 billion by 2028 from USD 29.0 billion in 2023, at a CAGR of 6.9% during the forecast period. Expanding the number of plasma collection centers allows market players to collect a larger volume of plasma from donors. This increased supply of raw materials becomes the foundation for producing a greater quantity of plasma-derived products, meeting the growing demand in the market. For instance, in December 2022, CSL Behring (Australia) announced the opening of a USD 900 million Plasma Fractionation Facility in Victoria, Australia. The new state-of-the-art facility can process up to 9.2 million plasma equivalent liters per annum.

“The hospitals and clinics segment is expected to dominate the market during the forecast period.”

Based on end user, the plasma fractionation market is segmented into research laboratories, hospitals and clinics, and academic institutes. In 2022, the clinics and hospitals segment accounted for the largest share of the global plasma fractionation market. The growing number of hospitals and clinics in emerging and developed economies, as well as the improvement in healthcare infrastructure, are attributed to this segment's major share in the market. Leading companies in this market are collaborating with hospitals to conduct clinical trials and promote awareness about the use of plasma products in the treatment of rare diseases. The demand for plasma products for the treatment of many rare and life-threatening disorders like hemophilia, PID, and COVID-19 is anticipated to increase as a result of such initiatives by companies and hospitals.

“The pulmonology application segment will witness the highest growth in the plasma fractionation market.”

Based on application, the plasma fractionation market is segmented into hematology, critical care, pulmonology neurology, immunology, , hemato-oncology, rheumatology, and other applications. In 2022, the pulmonology segment is expected to register the highest CAGR during the forecast period. The two major plasma products used in the treatment of various respiratory disorders are immunoglobulins and protease inhibitors. The main functions of immunoglobulins are the prevention and treatment of upper and lower respiratory tract infections. The market for pulmonology applications has grown significantly in recent years due to the significant growth in the usage of protease inhibitors, such as alpha-1-antitrypsin.

“North America will dominate the market during the forecast period.”

Based on region, the plasma fractionation market is further segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2022, North America accounted for the largest share of the plasma fractionation market, followed by Europe and the Asia Pacific. North America's dominance in the global market is due to the fact that top players are continuously engaged in adopting various organic and inorganic growth strategies such as collaborations, partnerships, and acquisitions to strengthen their market position. Major players in this industry in the area use the expansion of fractionation plants with cutting-edge technologies as a key growth strategy. The top competitors also focus on acquiring plasma collecting facilities to increase their market share in North America.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side - 70% and Demand Type - 30%

By Designation: Managers - 45%, Directors - 30%, and Executives - 25%

By Region: North America -25%, Europe -25%, Asia-Pacific -40%, Latin America-5%, Middle East -2.5% & Africa- 2.5%

List of Companies Profiled in the Report

CSL (Australia)

Takeda Pharmaceutical Company Limited (Japan)

Grifols, S.A. (Spain)

Octapharma AG (Switzerland)

Kedrion S.P.A (Italy)

LFB (France)

ADMA Biologics (US)

Sanquin (Netherlands)

China Biologic Products Holdings Inc. (China)

GC Pharma (Korea)

Hualan Bioengineering Co., Ltd. (China)

Japan Blood Products Organization (Japan)

Emergent BioSolutions (US)

Shanghai Raas Blood Products Co., Ltd. (China)

Intas Pharmaceuticals Ltd. (India)

Bharat Serum Vaccines Limited (India)

SK Plasma (Korea)

Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. (China)

Kamada (Israel)

Centurion Pharma (Istanbul)

Prothya Biosolutions (Netherlands)

PlasmaGen BioSciences Pvt. Ltd. (India)

Virchow Biotech Private Limited (India)

Fusion Healthcare (India)

Hemarus Therapeutics Limited (India)

Research Coverage:

This report provides a detailed picture of the plasma fractionation market. It aims at estimating the size and future growth potential of the market across different segments, such as the product, application, end-user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Reasons to Buy the Report:

The report provides insights on the following pointers:

Analysis of key drivers (growing use of immunoglobulins in various therapeutic areas, strategic expansion of plasma collection centers/inventories by market players, growing prevalence of respiratory diseases and AATD), restraints (high costs and limited reimbursements for plasma products, market disruption caused by recombinant alternatives), opportunities (government strategies increasing regional self-sufficiency), and challenges (stringent government regulations for maintaining safety and quality of plasma products) influencing the growth of the plasma fractionation market.

Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the plasma fractionation market.

Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various plasma fractionation facilities across key geographic regions.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the plasma fractionation market.

Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players like CSL (Australia), Takeda Pharmaceutical Company Limited (Japan), Grifols, S.A. (Spain), Octapharma AG (Switzerland), Kedrion S.P.A (Italy), among others in the plasma fractionation market.


  • INTRODUCTION
    • STUDY OBJECTIVES
    • MARKET DEFINITION
      • INCLUSIONS AND EXCLUSIONS
    • MARKET SCOPE
    • YEARS CONSIDERED
    • CURRENCY CONSIDERED
    • RESEARCH LIMITATIONS
    • STAKEHOLDERS
    • SUMMARY OF CHANGES
      • RECESSION IMPACT: PLASMA FRACTIONATION MARKET
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
      • INSIGHTS FROM PRIMARY EXPERTS
    • GROWTH FORECAST
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • STUDY ASSUMPTIONS
    • RISK ANALYSIS
    • RECESSION IMPACT ANALYSIS: PLASMA FRACTIONATION MARKET
      • Table GLOBAL INFLATION RATE PROJECTION, 2021–2027 (% GROWTH)
      • Table US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
      • Table US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • PLASMA FRACTIONATION MARKET OVERVIEW
    • NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY PRODUCT AND COUNTRY (2022)
    • PLASMA FRACTIONATION MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    • PLASMA FRACTIONATION MARKET, BY END USER, 2022
    • PLASMA FRACTIONATION MARKET: REGIONAL GROWTH OPPORTUNITIES
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • Table PLASMA FRACTIONATION MARKET: IMPACT ANALYSIS
      • DRIVERS
        • Table OFF-LABEL INDICATIONS OF INTRAVENOUS IMMUNOGLOBULIN (IVIG)
        • Table ON-LABEL INDICATIONS OF INTRAVENOUS IMMUNOGLOBULIN (IVIG)
        • Table NUMBER OF CLINICAL STUDIES ON IMMUNOGLOBULINS, BY COUNTRY/REGION (2020–2021)
        • Table NUMBER OF PATIENTS TREATED FOR TOP 15 TARGET CONDITIONS IN UK
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
    • PRICING ANALYSIS
      • Table AVERAGE SELLING PRICE OF PLASMA FRACTIONATION PRODUCTS, BY KEY PLAYER, 2022 (USD)
      • Table AVERAGE SELLING PRICE OF PLASMA FRACTIONATION PRODUCTS, BY REGION, 2021 (USD)
    • TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
    • VALUE CHAIN ANALYSIS
    • SUPPLY CHAIN ANALYSIS
    • ECOSYSTEM MARKET MAP
      • Table ROLE IN ECOSYSTEM (SUPPLY SIDE/DEMAND SIDE): PLASMA FRACTIONATION MARKET
    • PATENT ANALYSIS
    • KEY CONFERENCES AND EVENTS IN 2023–2024
      • Table PLASMA FRACTIONATION MARKET: LIST OF CONFERENCES AND EVENTS IN 2023–2024
    • REGULATORY ANALYSIS
      • Table NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • Table EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • Table ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • Table LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • Table MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • REGULATORY SCENARIO IN DIFFERENT COUNTRIES/REGIONS
    • PORTER’S FIVE FORCES ANALYSIS
      • Table PORTER’S FIVE FORCES ANALYSIS: PLASMA FRACTIONATION MARKET
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTES
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • INTENSITY OF COMPETITIVE RIVALRY
    • TECHNOLOGY ANALYSIS
      • COHN’S COLD ETHANOL PLASMA FRACTIONATION
      • GEL FILTRATION PLASMA FRACTIONATION
      • HUMAN PLASMA FRACTIONATION BY POLYETHYLENE GLYCOL
      • PLASMA FRACTIONATION BY AMMONIUM SULFATE
      • PLASMA FRACTIONATION BY CENTRIFUGATION
      • DEPTH FILTRATION PLASMA FRACTIONATION
      • PLASMA FRACTIONATION BY CHROMATOGRAPHY
    • KEY STAKEHOLDERS AND BUYING CRITERIA
    • KEY BUYING CRITERIA, BY END USER
    • PLASMA COLLECTION, BY VOLUME
      • US
      • CANADA
      • UK
      • JAPAN
      • INDIA
      • BRAZIL
    • PLASMA COLLECTION CENTERS
      • Table NUMBER OF PLASMA COLLECTION CENTERS, BY COMPANY, 2021–2022
  • PLASMA FRACTIONATION MARKET, BY PRODUCT
    • INTRODUCTION
      • Table PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
    • IMMUNOGLOBULINS
      • Table INTRAVENOUS IMMUNOGLOBULINS (IVIG) VS. SUBCUTANEOUS IMMUNOGLOBULINS (SCIG) THERAPY
      • Table PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY REGION, 2021–2028 (USD MILLION)
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY COUNTRY, 2021–2028 (USD MILLION)
      • Table EUROPE: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY COUNTRY, 2021–2028 (USD MILLION)
      • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY COUNTRY, 2021–2028 (USD MILLION)
      • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY COUNTRY, 2021–2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY COUNTRY, 2021–2028 (USD MILLION)
      • Table PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
      • IVIG
        • Table IVIG OFFERED BY KEY PLAYERS
        • Table IVIG MARKET, BY REGION, 2021–2028 (USD MILLION)
        • Table IVIG MARKET, BY REGION, 2021–2028 (METRIC TONS)
        • Table NORTH AMERICA: IVIG MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table NORTH AMERICA: IVIG MARKET, BY COUNTRY, 2021–2028 (METRIC TONS)
        • Table EUROPE: IVIG MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table EUROPE: IVIG MARKET, BY COUNTRY, 2021–2028 (METRIC TONS)
        • Table ASIA PACIFIC: IVIG MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table ASIA PACIFIC: IVIG MARKET, BY COUNTRY, 2021–2028 (METRIC TONS)
        • Table LATIN AMERICA: IVIG MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table LATIN AMERICA: IVIG MARKET, BY COUNTRY, 2021–2028 (METRIC TONS)
        • Table MIDDLE EAST & AFRICA: IVIG MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: IVIG MARKET, BY COUNTRY, 2021–2028 (METRIC TONS)
      • SCIG
        • Table SCIG OFFERED BY KEY PLAYERS
        • Table SCIG MARKET, BY REGION, 2021–2028 (USD MILLION)
        • Table SCIG MARKET, BY REGION, 2021–2028 (METRIC TONS)
        • Table NORTH AMERICA: SCIG MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table NORTH AMERICA: SCIG MARKET, BY COUNTRY, 2021–2028 (METRIC TONS)
        • Table EUROPE: SCIG MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table EUROPE: SCIG MARKET, BY COUNTRY, 2021–2028 (METRIC TONS)
        • Table ASIA PACIFIC: SCIG MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table ASIA PACIFIC: SCIG MARKET, BY COUNTRY, 2021–2028 (METRIC TONS)
        • Table LATIN AMERICA: SCIG MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table LATIN AMERICA: SCIG MARKET, BY COUNTRY, 2021–2028 (METRIC TONS)
        • Table MIDDLE EAST & AFRICA: SCIG MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: SCIG MARKET, BY COUNTRY, 2021–2028 (METRIC TONS)
      • OTHER IMMUNOGLOBULINS
        • Table OTHER IMMUNOGLOBULINS OFFERED BY KEY PLAYERS
        • Table OTHER IMMUNOGLOBULINS MARKET, BY REGION, 2021–2028 (USD MILLION)
        • Table OTHER IMMUNOGLOBULINS MARKET, BY REGION, 2021–2028 (METRIC TONS)
        • Table NORTH AMERICA: OTHER IMMUNOGLOBULINS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table NORTH AMERICA: OTHER IMMUNOGLOBULINS MARKET, BY COUNTRY, 2021–2028 (METRIC TONS)
        • Table EUROPE: OTHER IMMUNOGLOBULINS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table EUROPE: OTHER IMMUNOGLOBULINS MARKET, BY COUNTRY, 2021–2028 (METRIC TONS)
        • Table ASIA PACIFIC: OTHER IMMUNOGLOBULINS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table ASIA PACIFIC: OTHER IMMUNOGLOBULINS MARKET, BY COUNTRY, 2021–2028 (METRIC TONS)
        • Table LATIN AMERICA: OTHER IMMUNOGLOBULINS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table LATIN AMERICA: OTHER IMMUNOGLOBULINS MARKET, BY COUNTRY, 2021–2028 (METRIC TONS)
        • Table MIDDLE EAST & AFRICA: OTHER IMMUNOGLOBULINS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: OTHER IMMUNOGLOBULINS MARKET, BY COUNTRY, 2021–2028 (METRIC TONS)
    • COAGULATION FACTOR CONCENTRATES
      • Table PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY REGION, 2021–2028 (USD MILLION)
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY COUNTRY, 2021–2028 (USD MILLION)
      • Table EUROPE: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY COUNTRY, 2021–2028 (USD MILLION)
      • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY COUNTRY, 2021–2028 (USD MILLION)
      • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY COUNTRY, 2021–2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY COUNTRY, 2021–2028 (USD MILLION)
      • Table PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
      • FACTOR VIII
        • Table FACTOR VIII OFFERED BY KEY PLAYERS
        • Table FACTOR VIII MARKET, BY REGION, 2021–2028 (USD MILLION)
        • Table FACTOR VIII MARKET, BY REGION, 2021–2028 (MILLION IU)
        • Table NORTH AMERICA: FACTOR VIII MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table NORTH AMERICA: FACTOR VIII MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table EUROPE: FACTOR VIII MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table EUROPE: FACTOR VIII MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table ASIA PACIFIC: FACTOR VIII MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table ASIA PACIFIC: FACTOR VIII MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table LATIN AMERICA: FACTOR VIII MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table LATIN AMERICA: FACTOR VIII MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table MIDDLE EAST & AFRICA: FACTOR VIII MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: FACTOR VIII MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
      • FACTOR IX
        • Table FACTOR IX OFFERED BY KEY PLAYERS
        • Table FACTOR IX MARKET, BY REGION, 2021–2028 (USD MILLION)
        • Table FACTOR IX MARKET, BY REGION, 2021–2028 (MILLION IU)
        • Table NORTH AMERICA: FACTOR IX MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table NORTH AMERICA: FACTOR IX MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table EUROPE: FACTOR IX MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table EUROPE: FACTOR IX MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table ASIA PACIFIC: FACTOR IX MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table ASIA PACIFIC: FACTOR IX MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table LATIN AMERICA: FACTOR IX MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table LATIN AMERICA: FACTOR IX MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table MIDDLE EAST & AFRICA: FACTOR IX MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: FACTOR IX MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
      • VON WILLEBRAND FACTOR
        • Table VON WILLEBRAND FACTOR OFFERED BY KEY PLAYERS
        • Table VON WILLEBRAND FACTOR MARKET, BY REGION, 2021–2028 (USD MILLION)
        • Table VON WILLEBRAND FACTOR MARKET, BY REGION, 2021–2028 (MILLION LITER)
        • Table NORTH AMERICA: VON WILLEBRAND FACTOR MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table NORTH AMERICA: VON WILLEBRAND FACTOR MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table EUROPE: VON WILLEBRAND FACTOR MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table EUROPE: VON WILLEBRAND FACTOR MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table ASIA PACIFIC: VON WILLEBRAND FACTOR MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table ASIA PACIFIC: VON WILLEBRAND FACTOR MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table LATIN AMERICA: VON WILLEBRAND FACTOR MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table LATIN AMERICA: VON WILLEBRAND FACTOR MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table MIDDLE EAST & AFRICA: VON WILLEBRAND FACTOR MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: VON WILLEBRAND FACTOR MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
      • PROTHROMBIN COMPLEX CONCENTRATES
        • Table PROTHROMBIN COMPLEX CONCENTRATES OFFERED BY KEY PLAYERS
        • Table PROTHROMBIN COMPLEX CONCENTRATES MARKET, BY REGION, 2021–2028 (USD MILLION)
        • Table PROTHROMBIN COMPLEX CONCENTRATES MARKET, BY REGION, 2021–2028 (MILLION LITER)
        • Table NORTH AMERICA: PROTHROMBIN COMPLEX CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table NORTH AMERICA: PROTHROMBIN COMPLEX CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table EUROPE: PROTHROMBIN COMPLEX CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table EUROPE: PROTHROMBIN COMPLEX CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table ASIA PACIFIC: PROTHROMBIN COMPLEX CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table ASIA PACIFIC: PROTHROMBIN COMPLEX CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table LATIN AMERICA: PROTHROMBIN COMPLEX CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table LATIN AMERICA: PROTHROMBIN COMPLEX CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table MIDDLE EAST & AFRICA: PROTHROMBIN COMPLEX CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PROTHROMBIN COMPLEX CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
      • FIBRINOGEN CONCENTRATES
        • Table FIBRINOGEN CONCENTRATES OFFERED BY KEY PLAYERS
        • Table FIBRINOGEN CONCENTRATES MARKET, BY REGION, 2021–2028 (USD MILLION)
        • Table FIBRINOGEN CONCENTRATES MARKET, BY REGION, 2021–2028 (METRIC TONS)
        • Table NORTH AMERICA: FIBRINOGEN CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table NORTH AMERICA: FIBRINOGEN CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (METRIC TONS)
        • Table EUROPE: FIBRINOGEN CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table EUROPE: FIBRINOGEN CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (METRIC TONS)
        • Table ASIA PACIFIC: FIBRINOGEN CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table ASIA PACIFIC: FIBRINOGEN CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (METRIC TONS)
        • Table LATIN AMERICA: FIBRINOGEN CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table LATIN AMERICA: FIBRINOGEN CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (METRIC TONS)
        • Table MIDDLE EAST & AFRICA: FIBRINOGEN CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: FIBRINOGEN CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (METRIC TONS)
      • FACTOR XIII
        • Table FACTOR XIII OFFERED BY KEY PLAYERS
        • Table FACTOR XIII MARKET, BY REGION, 2021–2028 (USD MILLION)
        • Table FACTOR XIII, BY REGION, 2021–2028 (MILLION IU)
        • Table NORTH AMERICA: FACTOR XIII MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table NORTH AMERICA: FACTOR XIII MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table EUROPE: FACTOR XIII MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table EUROPE FACTOR XIII MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table ASIA PACIFIC: FACTOR XIII MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table ASIA PACIFIC: FACTOR XIII MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table LATIN AMERICA: FACTOR XIII MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table LATIN AMERICA: FACTOR XIII MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table MIDDLE EAST & AFRICA: FACTOR XIII MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: FACTOR XIII MARKET, BY COUNTRY, 2021–2028 (MILLION IU)
      • OTHER COAGULATION FACTOR CONCENTRATES
        • Table OTHER COAGULATION FACTOR CONCENTRATES MARKET, BY REGION, 2021–2028 (USD MILLION)
        • Table NORTH AMERICA: OTHER COAGULATION FACTOR CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table EUROPE: OTHER COAGULATION FACTOR CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table ASIA PACIFIC: OTHER COAGULATION FACTOR CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table LATIN AMERICA: OTHER COAGULATION FACTOR CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: OTHER COAGULATION FACTOR CONCENTRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    • ALBUMIN
      • RISING DEMAND IN MAINTAINING ONCOTIC PRESSURE AND CONDUCTING MEDICAL TREATMENTS TO DRIVE MARKET
        • Table ALBUMIN OFFERED BY KEY PLAYERS
        • Table PLASMA FRACTIONATION MARKET FOR ALBUMIN, BY REGION, 2021–2028 (USD MILLION)
        • Table PLASMA FRACTIONATION MARKET FOR ALBUMIN, BY REGION, 2021–2028 (MILLION LITER)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR ALBUMIN, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR ALBUMIN, BY COUNTRY, 2021–2028 (METRIC TONS)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR ALBUMIN, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR ALBUMIN, BY COUNTRY, 2021–2028 (METRIC TONS)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR ALBUMIN, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR ALBUMIN, BY COUNTRY, 2021–2028 (METRIC TONS)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR ALBUMIN, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR ALBUMIN, BY COUNTRY, 2021– 2028 (METRIC TONS)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR ALBUMIN, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR ALBUMIN, BY COUNTRY, 2021–2028 (METRIC TONS)
    • PROTEASE INHIBITORS
      • RISING PREVALENCE OF COPD AND OTHER RESPIRATORY DISEASES GLOBALLY TO DRIVE MARKET
        • Table PROTEASE INHIBITORS OFFERED BY KEY PLAYERS
        • Table PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY REGION, 2021–2028 (USD MILLION)
        • Table PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY REGION, 2021–2028 (MILLION IU)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY COUNTRY, 2021–2028 (MILLION IU)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY COUNTRY, 2021–2028 (MILLION IU)
    • OTHER PLASMA PRODUCTS
      • Table PLASMA FRACTIONATION MARKET FOR OTHER PLASMA PRODUCTS, BY REGION, 2021–2028 (USD MILLION)
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR OTHER PLASMA PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
      • Table EUROPE: PLASMA FRACTIONATION MARKET FOR OTHER PLASMA PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
      • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR OTHER PLASMA PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
      • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR OTHER PLASMA PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR OTHER PLASMA PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
  • PLASMA FRACTIONATION MARKET, BY APPLICATION
    • INTRODUCTION
      • Table PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
    • NEUROLOGY
      • RISING PREVALENCE OF AGE-RELATED NEUROLOGICAL DISORDERS TO DRIVE MARKET
        • Table DISABILITY-ADJUSTED LIFE YEARS (DALYS) FOR NEUROLOGICAL DISORDERS AND PROJECTED PERCENTAGE (2005 VS. 2015 VS. 2030)
        • Table PLASMA-DERIVED PRODUCTS AND APPLICATIONS IN NEUROLOGY
        • Table PLASMA FRACTIONATION MARKET FOR NEUROLOGY, BY REGION, 2021–2028 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR NEUROLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR NEUROLOGY, 2021–2028 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR NEUROLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR NEUROLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR NEUROLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
    • IMMUNOLOGY
      • ADVANCEMENTS IN GENETICS RESEARCH AND NOVEL THERAPEUTIC STRATEGIES TO DRIVE MARKET
        • Table PHYSICIAN-REPORTED PREVALENCE OF PRIMARY IMMUNODEFICIENCY DISEASES AMONG PATIENTS, BY REGION, 2013–2021
        • Table LIST OF FDA-APPROVED INDICATIONS FOR IMMUNOGLOBULINS IN IMMUNOLOGY
        • Table DIAGNOSIS DISTRIBUTION OF DIFFERENT CATEGORIES OF PRIMARY IMMUNODEFICIENCY DISEASES
        • Table PLASMA-DERIVED PRODUCTS AND THEIR APPLICATIONS IN IMMUNOLOGY
        • Table PLASMA FRACTIONATION MARKET FOR IMMUNOLOGY, BY REGION, 2021–2028 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR IMMUNOLOGY, 2021–2028 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
    • HEMATOLOGY
      • GROWING NUMBER OF HEMOPHILIA PATIENTS TO DRIVE DEMAND FOR COAGULATION FACTORS
        • Table NUMBER OF IDENTIFIED PATIENTS, BY INDICATION, 2021
        • Table PLASMA FRACTIONATION MARKET FOR HEMATOLOGY, BY REGION, 2021–2028 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR HEMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR HEMATOLOGY, 2021–2028 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR HEMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR HEMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR HEMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
    • CRITICAL CARE
      • INCREASING OFF-LABEL USE OF ALBUMIN TO DRIVE DEMAND FOR PLASMA-DERIVED CRITICAL CARE PRODUCTS
        • Table PLASMA-DERIVED PRODUCTS AND APPLICATIONS IN CRITICAL CARE
        • Table PLASMA FRACTIONATION MARKET FOR CRITICAL CARE, BY REGION, 2021–2028 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR CRITICAL CARE, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR CRITICAL CARE, 2021–2028 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR CRITICAL CARE, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR CRITICAL CARE, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR CRITICAL CARE, BY COUNTRY, 2021–2028 (USD MILLION)
    • PULMONOLOGY
      • RISING PREVALENCE OF ALPHA-1-ANTITRYPSIN DEFICIENCY AND COPD TO DRIVE MARKET
        • Table PLASMA-DERIVED PRODUCTS AND APPLICATIONS IN PULMONOLOGY
        • Table PLASMA FRACTIONATION MARKET FOR PULMONOLOGY, BY REGION, 2021–2028 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR PULMONOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR PULMONOLOGY, 2021–2028 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR PULMONOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR PULMONOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR PULMONOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
    • HEMATO-ONCOLOGY
      • RISING NUMBER OF BLOOD CANCER PATIENTS TO DRIVE MARKET
        • Table PLASMA-DERIVED PRODUCTS AND APPLICATIONS IN HEMATO-ONCOLOGY
        • Table PLASMA FRACTIONATION MARKET FOR HEMATO-ONCOLOGY, BY REGION, 2021–2028 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR HEMATO-ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR HEMATO-ONCOLOGY, 2021–2028 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR HEMATO-ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR HEMATO-ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR HEMATO-ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
    • RHEUMATOLOGY
      • INCREASING PREVALENCE OF RHEUMATIC ARTHRITIS IN DEVELOPED COUNTRIES TO DRIVE MARKET
        • Table PLASMA FRACTIONATION MARKET FOR RHEUMATOLOGY, BY REGION, 2021–2028 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR RHEUMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR RHEUMATOLOGY, 2021–2028 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR RHEUMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR RHEUMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR RHEUMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
    • OTHER APPLICATIONS
      • Table PLASMA-DERIVED PRODUCTS FOR OTHER APPLICATIONS
      • Table PLASMA FRACTIONATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
      • Table EUROPE: PLASMA FRACTIONATION MARKET FOR OTHER APPLICATIONS, 2021–2028 (USD MILLION)
      • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
      • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • PLASMA FRACTIONATION MARKET, BY END USER
    • INTRODUCTION
      • Table PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
    • HOSPITALS AND CLINICS
      • GROWING NUMBER OF SURGERIES AND INCREASING OFF-LABEL USE OF IMMUNOGLOBULINS TO DRIVE MARKET
        • Table PLASMA FRACTIONATION MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021–2028 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR HOSPITALS AND CLINICS, 2021–2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
    • CLINICAL RESEARCH LABORATORIES
      • INCREASING CLINICAL STUDIES ON NEW INDICATIONS FOR PLASMADERIVED PRODUCTS TO DRIVE MARKET
        • Table PLASMA FRACTIONATION MARKET FOR CLINICAL RESEARCH LABORATORIES, BY REGION, 2021–2028 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR CLINICAL RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR CLINICAL RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR CLINICAL RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR CLINICAL RESEARCH LABORATORIES, 2021–2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR CLINICAL RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
    • ACADEMIC INSTITUTES
      • GROWING STUDIES ON SAFETY AND EFFICACY OF PLASMA-DERIVED PRODUCTS TO DRIVE MARKET
        • Table PLASMA FRACTIONATION MARKET FOR ACADEMIC INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR ACADEMIC INSTITUTES, 2021–2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
  • PLASMA FRACTIONATION MARKET, BY REGION
    • INTRODUCTION
      • Table PLASMA FRACTIONATION MARKET, BY REGION, 2021–2028 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • US
        • Table US: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table US: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table US: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table US: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table US: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • CANADA
        • Table CANADA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table CANADA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table CANADA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table CANADA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table CANADA: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
    • EUROPE
      • Table EUROPE: PLASMA FRACTIONATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
      • Table EUROPE: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
      • Table EUROPE: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
      • Table EUROPE: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
      • Table EUROPE: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
      • Table EUROPE: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • GERMANY
        • Table GERMANY: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table GERMANY: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table GERMANY: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table GERMANY: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table GERMANY: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • UK
        • Table UK: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table UK: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table UK: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table UK: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table UK: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • FRANCE
        • Table NUMBER OF PEOPLE WITH BLEEDING DISORDERS IN FRANCE, 2012–2021
        • Table FRANCE: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table FRANCE: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table FRANCE: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table FRANCE: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table FRANCE: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • ITALY
        • Table PRODUCTION OF PLASMA PRODUCTS IN ITALY (2013, 2018, AND 2023)
        • Table ITALY: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table ITALY: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table ITALY: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table ITALY: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table ITALY: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • SPAIN
        • Table SPAIN: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table SPAIN: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table SPAIN: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table SPAIN: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table SPAIN: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • REST OF EUROPE
        • Table REST OF EUROPE: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table REST OF EUROPE: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table REST OF EUROPE: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table REST OF EUROPE: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table REST OF EUROPE: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
    • ASIA PACIFIC
      • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
      • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
      • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
      • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
      • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
      • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • CHINA
        • Table CHINA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table CHINA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table CHINA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table CHINA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table CHINA: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • JAPAN
        • Table MEAN PER CAPITA FACTOR VIII AND IX USE IN JAPAN, 2014 VS. 2018 (IN IU/TOTAL POPULATION)
        • Table PATIENTS WITH BLEEDING DISORDERS IN JAPAN, 2014 VS. 2021
        • Table JAPAN: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table JAPAN: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table JAPAN: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table JAPAN: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table JAPAN: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • AUSTRALIA
        • Table TOTAL IG (GRAMS) USED IN AUSTRALIA, 2008/09–2017/18
        • Table AUSTRALIA: BLOOD SECTOR OVERVIEW (2017–2018)
        • Table AUSTRALIA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table AUSTRALIA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table AUSTRALIA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table AUSTRALIA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table AUSTRALIA: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • INDIA
        • Table INDIA: NUMBER OF PATIENTS WITH BLEEDING DISORDERS, 2012–2021
        • Table INDIA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table INDIA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table INDIA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table INDIA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table INDIA: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • VIETNAM
        • Table VIETNAM: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table VIETNAM: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table VIETNAM: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table VIETNAM: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table VIETNAM: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • INDONESIA
        • Table INDONESIA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table INDONESIA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table INDONESIA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table INDONESIA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table INDONESIA: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • MALAYSIA
        • Table MALAYSIA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table MALAYSIA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table MALAYSIA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table MALAYSIA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table MALAYSIA: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table REST OF ASIA PACIFIC: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
    • LATIN AMERICA
      • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
      • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
      • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
      • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
      • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
      • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • BRAZIL
        • Table BRAZIL: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table BRAZIL: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table BRAZIL: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table BRAZIL: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table BRAZIL: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • REST OF LATIN AMERICA
        • Table REST OF LATIN AMERICA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
    • MIDDLE EAST & AFRICA
      • Table HEMOPHILIA PATIENTS IN MIDDLE EAST & AFRICA, BY COUNTRY, 2012–2020
      • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • TURKEY
        • Table TURKEY: DEMOGRAPHIC INDICATORS
        • Table TURKEY: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table TURKEY: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table TURKEY: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table TURKEY: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table TURKEY: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • SAUDI ARABIA
        • Table SAUDI ARABIA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table SAUDI ARABIA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table SAUDI ARABIA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table SAUDI ARABIA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table SAUDI ARABIA: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • EGYPT
        • Table EGYPT: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table EGYPT: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table EGYPT: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table EGYPT: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table EGYPT: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • UAE
        • Table UAE: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table UAE: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table UAE: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table UAE: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table UAE: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
      • REST OF MIDDLE EAST & AFRICA
        • Table HEMOPHILIA PATIENTS IN REST OF MIDDLE EAST & AFRICA, 2012 VS. 2017 VS. 2018
        • Table REST OF MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
        • Table REST OF MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2021–2028 (USD MILLION)
        • Table REST OF MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2021–2028 (USD MILLION)
        • Table REST OF MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
        • Table REST OF MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET, BY END USER, 2021–2028 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • KEY PLAYER STRATEGIES ADOPTED BY MAJOR PLAYERS
    • MARKET SHARE ANALYSIS
      • Table PLASMA FRACTIONATION MARKET: DEGREE OF COMPETITION
    • REVENUE SHARE ANALYSIS OF TOP PLAYERS IN PLASMA FRACTIONATION MARKET
    • COMPANY EVALUATION MATRIX FOR KEY PLAYERS IN PLASMA FRACTIONATION MARKET
      • STARS
      • EMERGING LEADERS
      • PERVASIVE PLAYERS
      • PARTICIPANTS
    • COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
      • Table END USER FOOTPRINT ANALYSIS (KEY PLAYERS)
      • Table PRODUCT FOOTPRINT ANALYSIS (KEY PLAYERS)
      • Table REGIONAL FOOTPRINT ANALYSIS (KEY PLAYERS)
    • COMPANY EVALUATION MATRIX FOR START-UPS/SMES IN PLASMA FRACTIONATION MARKET
      • PROGRESSIVE COMPANIES
      • STARTING BLOCKS
      • RESPONSIVE COMPANIES
      • DYNAMIC COMPANIES
    • COMPETITIVE BENCHMARKING OF START-UPS/SMES
      • Table DETAILED LIST OF KEY START-UPS/SMES: PLASMA FRACTIONATION MARKET
      • Table COMPETITIVE BENCHMARKING OF START-UPS/SMES: PLASMA FRACTIONATION MARKET
    • COMPETITIVE SCENARIOS AND TRENDS
      • Table KEY PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–JULY 2023
      • Table KEY DEALS, JANUARY 2021–JULY 2023
      • Table OTHER KEY DEVELOPMENTS, JANUARY 2021–JULY 2023
  • COMPANY PROFILES
    • KEY PLAYERS
      • CSL
        • Table CSL: COMPANY OVERVIEW
      • TAKEDA PHARMACEUTICAL COMPANY LIMITED
        • Table TAKEDA PHARMACEUTICAL COMPANY LIMITED: COMPANY OVERVIEW
      • GRIFOLS, S.A.
        • Table GRIFOLS, S.A.: COMPANY OVERVIEW
      • OCTAPHARMA AG
        • Table OCTAPHARMA AG: COMPANY OVERVIEW
      • KEDRION S.P.A
        • Table KEDRION S.P.A: COMPANY OVERVIEW
      • LFB
        • Table LFB: COMPANY OVERVIEW
      • ADMA BIOLOGICS, INC.
        • Table ADMA BIOLOGICS, INC.: COMPANY OVERVIEW
      • SANQUIN
        • Table SANQUIN: COMPANY OVERVIEW
      • CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.
        • Table CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.: COMPANY OVERVIEW
      • GC PHARMA
        • Table GC PHARMA: COMPANY OVERVIEW
      • HUALAN BIOENGINEERING CO., LTD.
        • Table HUALAN BIOENGINEERING CO., LTD.: COMPANY OVERVIEW
      • JAPAN BLOOD PRODUCTS ORGANIZATION
        • Table JAPAN BLOOD PRODUCTS ORGANIZATION: COMPANY OVERVIEW
      • EMERGENT
        • Table EMERGENT: COMPANY OVERVIEW
      • SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.
        • Table SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.: COMPANY OVERVIEW
      • INTAS PHARMACEUTICALS LTD.
        • Table INTAS PHARMACEUTICALS LTD.: COMPANY OVERVIEW
    • OTHER PLAYERS
      • BHARAT SERUMS AND VACCINES LIMITED
      • SK PLASMA
      • SICHUAN YUANDA SHUYANG PHARMACEUTICAL CO., LTD.
      • KAMADA PHARMACEUTICALS
      • CENTURION PHARMA
      • PROTHYA BIOSOLUTIONS B.V.
      • PLASMAGEN BIOSCIENCES PVT. LTD.
      • VIRCHOW BIOTECH
      • FUSION HEALTHCARE
      • HEMARUS
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
    • CUSTOMIZATION OPTIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings